86 related articles for article (PubMed ID: 11916008)
41. A potent genetic risk factor for restenosis.
Ohishi M; Fujii K; Minamino T; Higaki J; Kamitani A; Rakugi H; Zhao Y; Mikami H; Miki T; Ogihara T
Nat Genet; 1993 Dec; 5(4):324-5. PubMed ID: 8298638
[No Abstract] [Full Text] [Related]
42. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.
Zhang B; Ye S; Herrmann SM; Eriksson P; de Maat M; Evans A; Arveiler D; Luc G; Cambien F; Hamsten A; Watkins H; Henney AM
Circulation; 1999 Apr; 99(14):1788-94. PubMed ID: 10199873
[TBL] [Abstract][Full Text] [Related]
43. [The C(-1562)T polymorphism in the promoter of the matrix metalloproteinase-9 (MMP-9) gene and coronary atherosclerosis].
Goracy J; Goracy I; Brykczyński M; Peregud-Pogorzelska M; Naruszewicz M; Ciechanowicz A
Pol Arch Med Wewn; 2003 Nov; 110(5):1275-81. PubMed ID: 16736997
[TBL] [Abstract][Full Text] [Related]
44. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease.
Morgan AR; Zhang B; Tapper W; Collins A; Ye S
J Mol Med (Berl); 2003 May; 81(5):321-6. PubMed ID: 12728308
[TBL] [Abstract][Full Text] [Related]
45. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients.
Jormsjö S; Whatling C; Walter DH; Zeiher AM; Hamsten A; Eriksson P
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1834-9. PubMed ID: 11701474
[TBL] [Abstract][Full Text] [Related]
46. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study.
Pöllänen PJ; Karhunen PJ; Mikkelsson J; Laippala P; Perola M; Penttilä A; Mattila KM; Koivula T; Lehtimäki T
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1446-50. PubMed ID: 11557670
[TBL] [Abstract][Full Text] [Related]
47. Impact of the -455G>A promoter polymorphism in the B fibrinogen gene on stimulated fibrinogen production following bypass surgery.
Cotton JM; Webb KE; Mathur A; Martin JF; Humphries SE
Thromb Haemost; 2000 Nov; 84(5):926-7. PubMed ID: 11127884
[No Abstract] [Full Text] [Related]
48. Genetics and coronary artery disease.
Sinnaeve PR
Acta Cardiol; 2004 Dec; 59(6):581-93. PubMed ID: 15636440
[No Abstract] [Full Text] [Related]
49. Analysis of the genetic component of coronary artery disease.
Mansur Ade P
Arq Bras Cardiol; 2000 Jun; 74(6):531-6. PubMed ID: 10975144
[No Abstract] [Full Text] [Related]
50. Deciphering the Dark Matter of Complex Genetic Inheritance.
Crawford NP
Cell Syst; 2016 Mar; 2(3):144-6. PubMed ID: 27135361
[TBL] [Abstract][Full Text] [Related]
51. Enas A. Enas, M.D., F.A.C.C., Medical Director, Coronary Artery Disease in Indians (CADI) Study.
Asian Am Pac Isl J Health; 1998; 6(1):54-60. PubMed ID: 11567404
[No Abstract] [Full Text] [Related]
52. Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study.
Guizani I; Zidi W; Zayani Y; Nesrine F; Douik H; Sanhaji H; Mourali MS; Feki M; Allal-Elasmi M
Mol Biol Rep; 2022 Oct; 49(10):9171-9179. PubMed ID: 35960412
[TBL] [Abstract][Full Text] [Related]
53. Circulating Biomarkers Reflecting Destabilization Mechanisms of Coronary Artery Plaques: Are We Looking for the Impossible?
Kumric M; Borovac JA; Martinovic D; Ticinovic Kurir T; Bozic J
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34198543
[TBL] [Abstract][Full Text] [Related]
54. The association between Matrix Metallo-proteinases-9 (MMP-9) gene family polymorphisms and risk of Coronary Artery Disease (CAD): a systematic review and meta-analysis.
Hassanzadeh-Makoui R; Razi B; Aslani S; Imani D; Tabaee SS
BMC Cardiovasc Disord; 2020 May; 20(1):232. PubMed ID: 32429880
[TBL] [Abstract][Full Text] [Related]
55. Association between matrix metalloproteinase 9 C-1562T polymorphism and the risk of coronary artery disease: an update systematic review and meta-analysis.
Zhang MM; Chang XW; Hao XQ; Wang H; Xie X; Zhang SY
Oncotarget; 2018 Feb; 9(10):9468-9479. PubMed ID: 29507703
[TBL] [Abstract][Full Text] [Related]
56. Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease.
Mahmoodi K; Kamali K; Karami E; Soltanpour MS
J Res Med Sci; 2017; 22():8. PubMed ID: 28400830
[TBL] [Abstract][Full Text] [Related]
57. Matrix metalloproteinase-9 Gene-1562C>T Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis of 5468 Subjects.
Li YY; Yang XX; Zhou YH; Gong G; Geng HY; Kim HJ; Zhou CW; Qian Y; Wang XM; Wu J
Front Physiol; 2016; 7():212. PubMed ID: 27375491
[TBL] [Abstract][Full Text] [Related]
58. Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis.
Wang X; Shi LZ
J Zhejiang Univ Sci B; 2014 Mar; 15(3):256-63. PubMed ID: 24599689
[TBL] [Abstract][Full Text] [Related]
59. Matrix metalloproteinase-9 and paraoxonase 1 Q/R192 gene polymorphisms and the risk of coronary artery stenosis in Iranian subjects.
Fallah S; Seifi M; Ghasemi A; Firoozrai M; Samadikuchaksaraei A
J Clin Lab Anal; 2010; 24(5):305-10. PubMed ID: 20872564
[TBL] [Abstract][Full Text] [Related]
60. Personalized medicine in coronary artery disease: insights from genomic research.
Lee SH; Shin DJ; Jang Y
Korean Circ J; 2009 Apr; 39(4):129-37. PubMed ID: 19949601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
